Eventos cardiovasculares: um efeito de classe dos inibidores de COX-2 Cardiovascular events: a class effect by COX-2 inhibitors

Eventos cardiovasculares: um efeito de classe dos inibidores de COX-2 Cardiovascular events: a class effect by COX-2 inhibitors

Bibliographic Details
Main Authors:	Leila Fernandes Araujo, Alexandre de Matos Soeiro, Juliano de Lara Fernandes, Carlos Vicente Serrano Júnior
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Cardiologia (SBC) 2005-09-01
Series:	Arquivos Brasileiros de Cardiologia
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2005001600016

Similar Items

Clclo-oxygenase (COX) isoforms in the cardiovascular system : Implications for the future of COX-2 selective inhibitors
by: Hasan, Kamrul
Published: (2011)

CARDIOVASCULAR EFFECTS OF SELECTIVE COX-2 INHIBITORS IN RHEUMATIC DISEASES
by: Rimma Mikhailovna Balabanova
Published: (2010-06-01)

Expressão in vitro da cicloxigenase-2 (Cox2) no osteossarcoma exposto a inibidores seletivo da Cox2 /
by: Bersano, Paulo Ricardo de Oliveira.
Published: (2011)

Expressão in vitro da cicloxigenase-2 (Cox2) no osteossarcoma exposto a inibidores seletivo da Cox2
by: Bersano, Paulo Ricardo de Oliveira [UNESP]
Published: (2014)

Selective COX-2 inhibitor reduces bone healing in bone defects Inibidor seletivo de COX-2 reduz reparo em defeitos ósseos
by: Bruno César de Vasconcelos Gurgel, et al.
Published: (2005-12-01)

New horizons in the roles and associations of COX-2 and novel natural inhibitors in cardiovascular diseases
by: Wujun Chen, et al.
Published: (2021-09-01)

Select dietary phytochemicals function as inhibitors of COX-1 but not COX-2.
by: Haitao Li, et al.
Published: (2013-01-01)

Cox, Lynn: Class, April 22
Published: ()

Adverse Effects of COX-2 Inhibitors
by: Jagdish N. Sharma, et al.
Published: (2005-01-01)

COX-2 Inhibitors and Gastric Cancer
by: Zhen Wang, et al.
Published: (2014-01-01)

COX-2 inhibitors in oesophageal cancer
by: Ranka, Satish
Published: (2014)

Effect of Cox-II inhibitor on biochemical markers in cardiovascular-related adverse effects
by: Chih-Hui Min, et al.
Published: (2009)

Inhibidores de la COX-2, y eventos cardiovasculares a la luz de la historia del rofecoxib
by: Marcela Botargues
Published: (2004-11-01)

COX-2 Inhibitors for Cancer Treatment in Dogs
by: Andrigo Barboza De Nardi*, Talita Mariana Morata Raposo1, Rafael Ricardo Huppes1, Carlos Roberto Daleck2 and Renée Laufer Amorim3
Published: (2011-10-01)

Statistical inference for some classes of Cox processes
by: Ramesh, Nadarajah Iyer
Published: (1992)

Análise crítica do uso de inibidores seletivos de Cox-2
by: Gilberto Santos Novaes
Published: (2009-07-01)

COX-2 SPECIFIC INHIBITORS (COXIBS) CRISIS
by: Abbas Ali Mansour
Published: (2003-12-01)

Radiolabeled COX-2 Inhibitors for Non-Invasive Visualization of COX-2 Expression and Activity — A Critical Update
by: Torsten Kniess, et al.
Published: (2013-05-01)

An observational study of the discrediting of COX-2 NSAIDs in Australia: Vioxx or class effect?
by: Parkinson Lynne, et al.
Published: (2011-11-01)

The relationship between Cox-2 inhibitors and cardiovascular risk: a retrospective analysis using the Veteran Affairs (VA) database
by: Motsko, Stephen Paul
Published: (2008)

Expression of cyclooxygenase-2(COX-2) in hypopharyngeal cancer and modulation of apoptosis and cell cycle progression by COX-2- specific inhibitors
by: Peng Jyh Ping, et al.
Published: (2003)

The Fall of Titans: The Need to Reassess COX-2 Inhibitors
by: Steven Lin
Published: (2020-12-01)

Rofecoxib: a new selective COX-2 inhibitor.
by: Rajadhyaksha V, et al.
Published: (2001-01-01)

Seizure following the Use of the COX-2 Inhibitor Etoricoxib
by: Valentina Arnao, et al.
Published: (2017-01-01)

Expression of Beta-catenin, COX-2 and iNOS in Colorectal Cancer: Relevance of COX-2 and iNOS Inhibitors for Treatment in Malaysia
by: Seok Kwan Hong, et al.
Published: (2004-01-01)

CELEBREX: THE FIRST SPECIFIC INHIBITOR OF COX-2: NEW DATA
by: E L Nassonov
Published: (2000-08-01)

Design and Synthesis of Imidazopyrazolopyridines as Novel Selective COX-2 Inhibitors
by: Mohamed G. Badrey, et al.
Published: (2015-08-01)

Multifocal fixed drug eruption with COX-2 inhibitor-celecoxib
by: Shikha Chugh, et al.
Published: (2013-01-01)

The effects of bisphosphonates and COX-2 inhibitors on the bone remodelling unit
by: Valkealahti, M. (Maarit)
Published: (2008)

The selective COX-2 inhibitor celecoxib modulates sphingolipid synthesiss⃞
by: Susanne Schiffmann, et al.
Published: (2009-01-01)

Cyclo-Oxygenase (COX) Inhibitors and Cardiovascular Risk: Are Non-Steroidal Anti-Inflammatory Drugs Really Anti-Inflammatory?
by: Shanzana Khan, et al.
Published: (2019-08-01)

Analysis of the role of Cox20 during the early steps of Cox2 biogenesis
by: Lorenzi, Isotta
Published: (2016)

Investigating the role of COX-1 and COX-2 in Toll-Like Receptor responses
by: Wright, William
Published: (2014)

Cyclooxygenase (COX) Inhibitors and the Newborn Kidney
by: Wei Qi, et al.
Published: (2012-10-01)

Thiazoles and Thiazolidinones as COX/LOX Inhibitors
by: Konstantinos Liaras, et al.
Published: (2018-03-01)

Effect of COX and LOX inhibitors on melanoma
by: Da Costa Rocha, Ines Isabel
Published: (2012)

The role of the type-2 isoform of the cyclooxygenase enzyme (COX-2) in human parturition : potential benefits of selective COX-2 inhibitors in the management of preterm labour
by: Sawdy, Robert John
Published: (2003)

Viscum album-mediated COX-2 inhibition implicates destabilization of COX-2 mRNA.
by: Chaitrali Saha, et al.
Published: (2015-01-01)

The COX-2 expression of oral cancer and its precancerous lesions and the inhibition of propolis on COX-2
by: Hsin-I Chi, et al.
Published: (2002)

A Cox-based Risk Prediction Model for Early Detection of Cardiovascular Disease
by: Jia, Xiaona
Published: (2018)